Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | LSS | P48449 | 2/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29449297 | 0.95 | TP53 (0.35) | CYP1A2MAPTTP53PRKCASIGMAR1 | |
| SCHEMBL29449308 | 0.95 | TP53 (0.35) | CYP1A2MAPTTP53PRKCASIGMAR1 | |
| SCHEMBL29449298 | 0.95 | TP53 (0.35) | CYP1A2MAPTTP53PRKCASIGMAR1 | |
| SCHEMBL29449319 | 0.95 | TP53 (0.35) | CYP1A2MAPTTP53PRKCASIGMAR1 | |
| SCHEMBL29449292 | 0.95 | TP53 (0.35) | CYP1A2MAPTTP53PRKCASIGMAR1 | |
| SCHEMBL29449304 | 0.95 | TP53 (0.35) | CYP1A2MAPTTP53PRKCASIGMAR1 | |
| SCHEMBL29449314 | 0.94 | CYP1A2 (0.40) | CYP1A2MAPTTP53 | |
| SCHEMBL29449306 | 0.86 | CYP1A2 (0.43) | CYP1A2TP53PRKCASIGMAR1LSS | |
| SCHEMBL29449301 | 0.79 | CYP1A2 (0.48) | CYP1A2MAPTTP53PRKCAEPHX1 | |
| SCHEMBL28414746 | 0.76 | LMNA (0.42) | CYP1A2MAPTTP53SIGMAR1LSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11851547-B2 | Cyclohexane triester based plasticizer composition and resin composition comprising the same | LG CHEM, LTD. (KR) | 2023-12-26 | — | — | US | disclosed |
| EP-3875526-B1 | CYCLOHEXANE TRIESTER-BASED PLASTICIZER COMPOSITION, AND RESIN COMPOSITION COMPRISING THE SAME | LG CHEMICAL LTD (KR) | 2022-10-19 | — | — | EP | disclosed |
| CN-112166147-B | Cyclohexanetriester plasticizer composition and resin composition containing the same | 株式会社LG化学 | 2022-04-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11851547-B2 | Cyclohexane triester based plasticizer composition and resin composition comprising the same | TRRAP, WDR12, CTRC | CYP1A2 1414/4885MAPT 2249/4885TP53 2791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.